ABN’s Lab ICD-10 Search Tool
What is the A-List?
A-LIST is designed as a search tool to aid in the selection of medically acceptable diagnostic codes for test groups included in the National Coverage Determination (NCD) and Local Coverage Determination (LCD) documents. The documents are in PDF format and easily searched. The responsibility for properly and correctly navigating the A-LIST for Medicare coding remains with the physicians and their staff. The A-LIST is simply a search tool offered for the convenience of physicians and not a substitute for the professional judgment required of the physicians. The use of this search tool constitutes a waiver of all claims against MMC, its affiliates and employees, arising from the use of the search tool and coding taken therefrom.
How do I find the diagnostic information I need?
The home page contains the following information:
- Complete National Coverage Determination (NCD) document.
- National Coverage Determination (NCD) test groups.
- Local Coverage Determination (LCD) test groups.
Within each test group, there are 3 main documents:
- Complete NCD/LCD specific to test group
- Acceptable ICD-10 codes associated with MMC test
- Details such as Description, Indications, and Limitations (Time-specific information and coding suggestions may be found in Details).
Additional Coding Guidelines for CMS tests referred to in this section are found in the front section of the complete NCD document.) To search for specific information, simply click on the desired category of the test group. A document will open in a PDF format.
Additional information, including shortcuts, can be found in this document.
The Medicare National Coverage Determinations (NCD) Coding Policy Manual and Change Report (ICD-10-CM) from the U.S. Department of Health & Human Services Centers for Medicare & Medicaid Services provides complete NCD documentation.
Local Coverage Determination (LCD)
PLEASE READ CAREFULLY
Local Coverage Determination (LCD) are written differently than the NCD documents. Some test groups have specific coverage determinations for each test, and some test groups have special conditions.
| Test Group Coverage Determination | CPT | MMC Tests | Code Lookup Document | Details | Date Published |
|---|---|---|---|---|---|
Acute Hepatitis Panel / Hepatitis Panel | 80074 | Hepatitis Panel W/Rfx, Acute | 190.33 | NCD January 2026 | |
Alpha-fetoprotein | 82105 | AFP Tumor Marker, Serum Integrated Screen Part 2 Maternal Quad Screen Maternal Serum AFP Maternal Serum Screen 5 | 190.25 | NCD January 2026 | |
Allergy Testing | 82785 | Gammaglobulin (immunoglobulin); IgE | A56558 | LCD 1/1/2025 | |
Allergy Testing | 86003 | Allergen specific IgE, each allergen | A56558 | ||
| Assays for Vitamins and Metabolic Function | 82180 | Assay of ascorbic acid | A56416 | LCD 10/01/23 | |
| Assays for Vitamins and Metabolic Function | 82306 | Vitamin D 25 hydroxy | A56416 | ||
| Assays for Vitamins and Metabolic Function | 82379 | Assay of carnitine | A56416 | ||
| Assays for Vitamins and Metabolic Function | 82607 | Vitamin B12 | A56416 | ||
| Assays for Vitamins and Metabolic Function | 82652 | Vitamin D,1,25-Dihydroxy | A56416 | ||
| Assays for Vitamins and Metabolic Function | 82746 | Assay of folic acid serum | A56416 | ||
| Assays for Vitamins and Metabolic Function | 83090 | Assay of homocystine | A56416 | ||
| Assays for Vitamins and Metabolic Function | 83698 | Assay of lipoprotein pla2 | A56416 | ||
| Assays for Vitamins and Metabolic Function | 84207 | Assay of vitamin B6 | A56416 | ||
| Assays for Vitamins and Metabolic Function | 84252 | Assay of vitamin B2 | A56416 | ||
| Assays for Vitamins and Metabolic Function | 84425 | Assay of vitamin B1 | A56416 | ||
| Assays for Vitamins and Metabolic Function | 84446 | Assay of vitamin E | A56416 | ||
| Assays for Vitamins and Metabolic Function | 84590 | Assay of vitamin A | A56416 | ||
| Assays for Vitamins and Metabolic Function | 84597 | Assay of vitamin K | A56416 | ||
| Assays for Vitamins and Metabolic Function | 85385 | Fibrinogen antigen | A56416 | ||
| Assays for Vitamins and Metabolic Function | 86352 | Cell function assay w/ stim | A56416 | ||
| Biomarkers Overview | 81162 | BRCA 1&2 seq & full dup/del | A56541 | LCD 1/1/2024 |
|
| Biomarkers Overview | 81227 | Cyp2c9 gene | A56541 | ||
| Biomarkers Overview | 81240 | F2 gene - Prothrombin gene | A56541 | ||
| Biomarkers Overview | 81241 | F5 gene - Factor V Leiden | A56541 | ||
| Biomarkers Overview | 81291 | Mthfr gene | A56541 | ||
| Biomarkers Overview | 81376 81382 | A56541 | |||
| Biomarkers Overview | HLA typing for celiac disease | A56541 | |||
| Biomarkers Overview | 81381 | HLA-B 5701 | A56541 | ||
| Biomarkers Overview | 81355 | Vkorc1 gene | A56541 | ||
| Biomarkers for Oncology | 81206/81207 | BCR/ABL gene | A52986 | LCD 1/1/2025 | |
| Biomarkers for Oncology | 81270 | JAK2 | A52986 | ||
| Biomarkers for Oncology | 81402 | MPL | A52986 | ||
| Blood Counts (This test group provides codes that DO NOT support medical necessity) | 85007 | CBC w/ Manual Diff | 190.15 | NCD January 2026 | |
| Blood Counts | 85008 | Peripheral Smear | 190.15 | NCD January 2026 | |
| Blood Counts | 85013 | Hematocrit (Spun), Body Fluid | 190.15 | NCD January 2026 | |
| Blood Counts | 85014 | Hematocrit (Spun), Body Fluid | 190.15 | NCD January 2026 | |
| Blood Counts | 85018 | Hemoglobin | 190.15 | NCD January 2026 | |
| Blood Counts | 85025 | CBC With Auto Diff | 190.15 | NCD January 2026 | |
| Blood Counts | 85027 | Complete Blood Count CBC Without Diff | 190.15 | NCD January 2026 | |
| Blood Counts | 85048 | White Blood Count Total Eosinophil WBC Autodiff Eosinophil Absolute | 190.15 | NCD January 2026 | |
| Blood Counts | 85049 | Platelet Count | 190.15 | NCD January 2026 | |
CA 15-3/CA 27.29Tumor Antigen by Immunoassay | 86300 | Cancer AG 15-3 (CA15-3) CA 15-3, CSF Cancer Ag 27.29, Serum | 190.29 | NCD January 2026 | |
| CA 19-9 Tumor Antigen by immunoassay | 86301 | Carbohydrate AG 19-9(CA19-9) CA 19-9, CSF | 190.26 | NCD January 2026 | |
| CA 125 Tumor Antigen by immunoassay | 86301 | Cancer AG 125 CA 125 CSF CA 125 Peritoneal Fluid CA 125 Pleural Fluid | 190.28 | NCD January 2026 | |
| Carcinoembryonic Antigen (CEA) | 86301 | CEA CEA, CSF Fluid CEA, Pericardial Fluid CEA, Peritoneal Fluid CEA, Pleural Fluid | 190.26 | NCD January 2026 | |
| Collagen Crosslinks, Any Method | 82523 | Collegen Cross Linked, 24hr Ur Collagen Cross Linked,Random Collagen 1c-Telopep (CTX) | 190.19 | NCD January 2026 | |
C-Reactive Protein (CRP) | 86141 | Cardio CRP CRP, High Sensitivity | hsCRP A 56643 | LCD 11/07/19 | |
| Digoxin Therapeutic Drug Assay | 80162 | Digoxin | 190.24 | NCD January 2026 | |
| Drug Testing | G0480/G0481 G0482/G0483 | Each drug classification-confirmation | A56645 | LCD 10/1/2024 | |
| Drug Testing | 80305/80306 80307 | Drug Scrn Qualitive High Compl Urine Drug Screen-Conf (C.O.C) Alcohol Ethanol Except Breath | A56645 | ||
| Drug Testing | 83789 | UDS Mult Drug Classes | A56645 | ||
| Drug Testing | Iodine | A56645 | |||
| Fecal Occult Blood Test | 86301 | Stool Occult Blood Occult Blood-Colorectal Screen | 190.34 | Chart | NCD January 2026 |
| Fecal Occult Blood Test | 82272 | Stool Occ Blood Non Screening | 190.34 | ||
| Gamma Glutamyl Transferase (GGT) | 82977 | GGTP | 190.32 | NCD January 2026 | |
| Glucose (Blood) Testing | 82962 | Glucose Meter | 190.20 | NCD January 2026 | |
| Glucose (Blood) Testing | 83036 | Glucose 2 Hr P P Glucose | 190.20 | NCD January 2026 | |
| Glycated Hemoglobin(A1C)/ Glycated Protein | 82985 | Fructosamine | 190.21 | NCD January 2026 | |
| Glycated Hemoglobin(A1C)/ Glycated Protein | 83036 | A1C Hemoglobin | 190.21 | NCD January 2026 | |
| Histocompatibility Testing | 86812 | HLA-B27 Antigen | 190.1 | NCD Feb 2017 | |
| Human Chorionic Gonadotropin (HCG) | 84702 | Total HCG Integrated Screen Part 2 Maternal Quad Screen Maternal Serum Screen 5 HCG Total, Non Pregnant | 190.27 | NCD January 2026 | |
| Human Immunodeficiency Virus (HIV) Testing (Diagnosis) | 86689 | HIV AB HIV1 WB W/Rflx TO HIV2 HIV-1 AB, Western Blot, Serum | 190.14 | NCD January 2026 | |
| Human Immunodeficiency Virus (HIV) Testing (Diagnosis) | 86703 | HIV1/HIV2 AB, EIA SCR W/Rflx | 190.14 | NCD January 2026 | |
| Human Immunodeficiency Virus (HIV) Testing (Diagnosis) | 87535 | HIV-1 RNA, QL TMA | 190.14 | NCD January 2026 | |
| Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring) | 87536 | HIV1 RNA QN, PCR | 190.14 | NCD January 2026 | |
| Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring) | 87539 | HIV1 RNA QN, BDNA | 190.13 | NCD January 2026 | |
| Iron (Serum) Studies | 82728 | Ferritin | 190.18 | NCD January 2026 | |
| Iron (Serum) Studies | 86301 | Iron Total Iron, 24hr Urine Mayo Iron, Liver Tissue | 190.18 | NCD January 2026 | |
| Iron (Serum) Studies | 83550 | Total Iron Binding Cap & Iron Iron & TIBC W/% Saturation | 190.18 | NCD January 2026 | |
| Iron (Serum) Studies | 84466 | Transferrin, Serum Carbohydrate Def Transferrin | 190.18 | NCD January 2026 | |
| Lipid Testing | 80061 | Lipid Panel | 190.23 | NCD January 2026 | |
| Lipid Testing | 82465 | Cholesterol Lipoprotein Fractionation Lipid Phenotype Profile | 190.23 | NCD January 2026 | |
| Lipid Testing | 83700 | Lipid Phenotype Profile | 190.23 | NCD January 2026 | |
| Lipid Testing | 83701 | VAP TM Cholesterol Lipoprotein Fractionation | 190.23 | NCD January 2026 | |
| Lipid Testing | 83718 | HDL Cholesterol | 190.23 | NCD January 2026 | |
| Lipid Testing | 84478 | Triglycerides VAP Tm Cholesterol Lipoprotein Fractionation Lipid Phenotype Profile VLDL Cholesterol | 190.23 | NCD January 2026 | |
| Lipid Testing | 83721 | LDL Cholesterol, Direct | 190.23 | NCD January 2026 | |
| Pap Smear | P3000 | Pap Smear | Chart | NCD July 2022 | |
| Pap Smear | G0123 | Thin Prep Pap Screen Thin Prip Pap W/Rfx HPV | |||
| Pap Smear | G0145 | T Prep Screen Rfx/Hpv (Imaged) Thin Prep Pap-Screen (Imaged) | |||
| Partial Thromboplastin Time (PTT) | 85730 | DIC Screen (ITXM) ITXM Lup Anti-Coag Pnl (ITXM) Lupus Anticoagulant Evaluation Lupus Coag Screen (ITXM) Mixing/Correction Studies Partial Thromb Time PTT Von Willebrand Panel Von Willebrand Screen (ITXM) | 190.16 | NCD January 2026 | |
| Prostate Specific Antigen | 84153 | Prostatic Specific Antigen PSA, Free & Total PSA, Post-Prostatectomy | 190.31 | NCD January 2026 | |
| G0103 | Prostatic Specific Antigen, Screen | 190.31 | Chart | NCD January 2026 | |
| Prothrombin Time (PT) | 86301 | INR DIC Screen (ITXM) ITXM Lup Anti-Coag Pnl (ITXM) Lupus Coag Screen (ITXM) Mixing/Correction Studies | 190.17 | NCD January 2026 | |
| Thyroid Testing | 84436 | Thyroxine (T4) | 190.22 | NCD January 2026 | |
| Thyroid Testing | 86301 | Free T4 T4, Free Direct Dialysis | 190.22 | NCD January 2026 | |
| Thyroid Testing | 84443 | TSH TSH 3rd Generation (High Sens) TSH With Reflex | 190.22 | NCD January 2026 | |
| Thyroid Testing | 84479 | T3 Uptake T-Uptake (TBI) | 190.22 | NCD January 2026 | |
| Urine Culture, Bacterial | 87086 | Urine Culture | 190.12 | NCD January 2026 |
Other Resources
Medicare NCDs
Search and download directly from the Medicare Coverage Database site: National Coverage NCD Report Results
Medicare Preventative Services Chart
Use this tool for finding coverage information for preventative lab services including Pap tests, PSA, and occult blood/colorectal screening: Medicare Preventive Services
LCD-Active Test Group Index
Use this index to view and search an alphabetical list of all active LCDs and articles for applicable CPT/HCPCs codes: Medicare Jurisdiction L